RS Investment Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q2 | $1.89M | Buy |
24,250
+3,130
| +15% | +$244K | 0.02% | 306 |
|
|
2016
Q1 | $1.74M | Sell |
21,120
-78,120
| -79% | -$6.44M | 0.02% | 306 |
|
|
2015
Q4 | $10.4M | Buy |
99,240
+44,180
| +80% | +$4.63M | 0.09% | 228 |
|
|
2015
Q3 | $5.8M | Buy |
55,060
+22,490
| +69% | +$2.37M | 0.05% | 262 |
|
|
2015
Q2 | $4.46M | Sell |
32,570
-1,330
| -4% | -$182K | 0.04% | 277 |
|
|
2015
Q1 | $4.23M | Sell |
33,900
-60,500
| -64% | -$7.54M | 0.04% | 284 |
|
|
2014
Q4 | $8.53M | Buy |
+94,400
| New | +$8.53M | 0.08% | 253 |
|
|
2013
Q4 | – | Sell |
-56,200
| Closed | -$4.06M | – | 331 |
|
|
2013
Q3 | $4.06M | Sell |
56,200
-308,370
| -85% | -$22.3M | 0.03% | 257 |
|
|
2013
Q2 | $20.3M | Buy |
+364,570
| New | +$20.3M | 0.15% | 161 |
|